Showing results (61-70 of 223) with videos related to

Sort By:
Pageof 23
Brain : a Journal of Neurology|December 1, 2014
Vision and vision-related outcome measures in multiple sclerosisLaura J Balcer, David H Miller, Stephen C Reingold, et al.
Annals of Neurology|February 1, 2011
Phase III dose-comparison study of glatiramer acetate for multiple sclerosisGiancarlo Comi, Jeffrey A Cohen, Douglas L Arnold, et al.
Cleveland Clinic Journal of Medicine|February 16, 2006
Multiple sclerosis: treating symptoms, and other general medical issuesMyla D Goldman, Jeffrey A Cohen, Robert J Fox, et al.
Aesthetic Surgery Journal|April 22, 2026
Effect of Botulinum Toxin Injection Intervals on the Irreversibility of Targeted Muscle Paralysis: An Electromyographic StudyMohamed Badie Ahmed, Mariam Al Aloosi, Jeffrey A Cohen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 1, 2005
Subjective cognitive complaints relate to mild impairment of cognition in multiple sclerosisRuth Ann Marrie, Gordon J Chelune, Deborah M Miller, et al.
The Lancet. Neurology|April 21, 2012
Disability outcome measures in multiple sclerosis clinical trials: current status and future prospectsJeffrey A Cohen, Stephen C Reingold, Chris H Polman, et al.
Cleveland Clinic Journal of Medicine|April 3, 2023
Reproductive issues and multiple sclerosis: 20 questionsAlise K Carlson, Daniel Ontaneda, Mary R Rensel, et al.
Frontiers in Neurology|May 2, 2022
Treatment Challenges in Multiple Sclerosis - A Continued Role for Glatiramer Acetate?Massimiliano Mirabella, Pietro Annovazzi, Wallace Brownlee, et al.
Neurology. Clinical Practice|March 13, 2019
Movement disorders in early MS and related diseases: A prospective observational studyHesham Abboud, Xin Xin Yu, Konrad Knusel, et al.
Medical Hypotheses|May 4, 2007
Does treating schizophrenia reduce the chances of developing amyotrophic lateral sclerosis?Elijah W Stommel, David Graber, Justin Montanye, et al.
Pageof 23